ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
US Tech 100
21,165.17
-0.66%
Dow Jones
44,424.25
-0.32%
Brent Oil
77.625
0.00%
Bitcoin
104,754.90
-0.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. OSE Immunotherapeutics (OSE) Quote

OSE Immunotherapeutics

OSE Immunotherapeutics (OSE)

EU
6.37
-0.04
(-0.62%)
Closed January 24 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.37
Bid
6.35
Ask
6.45
Volume
66,700
6.36 Day's Range 6.57
3.115 52 Week Range 11.58
Market Cap
138.661M
Previous Close
6.41
Open
6.42
Last Trade
170
@
6.37
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
142,588
Shares Outstanding
21,767,777
Dividend Yield
-
PE Ratio
-6.03
Earnings Per Share (EPS)
-1.06
Revenue
2.23M
Net Profit
-23M

About OSE Immunotherapeutics

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.ose-immuno.com
Headquarters
Nantes, Loire-atlantique, Fra
Founded
-
OSE Immunotherapeutics is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker OSE. The last closing price for OSE Immunotherapeutics was 6.41 €. Over the last year, OSE Immunotherapeutics shares have traded in a share price range of 3.115 € to 11.58 €.

OSE Immunotherapeutics currently has 21,767,777 shares outstanding. The market capitalization of OSE Immunotherapeutics is 139.53 € million. OSE Immunotherapeutics has a price to earnings ratio (PE ratio) of -6.03.

Ask ADVFN Intelligence (AI)

OSE Latest News

More News

OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer

OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer   NANTES, France, January 13, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE...

January 13 2025
GlobeNewswire Inc.

OSE Immunotherapeutics annonce la nomination du Dr. Sonya Montgomery au poste de Chief Development Officer

OSE Immunotherapeutics annonce la nomination du Dr. Sonya Montgomery au poste de Chief Development Officer OSE Immunotherapeutics annonce la nomination du Dr. Sonya Montgomery au poste de Chief...

January 13 2025
UK Regulatory

OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer

OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer   NANTES, France, January 13...

January 13 2025
UK Regulatory

Ose Immunotherapeutics : Informations relatives au nombre total de droits de vote et d’actions composant le capital

Ose Immunotherapeutics : Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant...

January 06 2025
UK Regulatory

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO

OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de l’anti-IL-7R Lusvertikimab dans la rectocolite hémorragique au 20ème congrès de l’ECCO Un abstract clinique sur les...

December 18 2024
UK Regulatory

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO A clinical abstract on the induction results from the CoTikiS...

December 18 2024
UK Regulatory

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ARTEMIA: Clinical trial protocol approved globally. Most countries and sites...

December 11 2024
GlobeNewswire Inc.

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé

OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®, son vaccin thérapeutique contre le cancer en développement avancé OSE Immunotherapeutics annonce des avancées cliniques...

December 11 2024
UK Regulatory

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary...

December 11 2024
UK Regulatory

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital

OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant le Capital Informations Relatives au Nombre Total de Droits de Vote et d’Actions Composant...

December 04 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.32-4.783258594926.696.766.32674876.53669068DE
4-0.81-11.28133704747.187.856.32890466.96424508DE
12-3.69-36.679920477110.0611.586.321425888.46464585DE
26-0.53-7.681159420296.911.586.321800578.32520459DE
522.48563.9639639643.88511.583.1151723857.24575029DE
156-2.74-30.07683863899.1111.582.7051086966.32570052DE
2602.0748.13953488374.315.452.7051030097.42342883DE

OSE - Frequently Asked Questions (FAQ)

What is the current OSE Immunotherapeutics share price?
The current share price of OSE Immunotherapeutics is 6.37 €
How many OSE Immunotherapeutics shares are in issue?
OSE Immunotherapeutics has 21,767,777 shares in issue
What is the market cap of OSE Immunotherapeutics?
The market capitalisation of OSE Immunotherapeutics is EUR 139.53M
What is the 1 year trading range for OSE Immunotherapeutics share price?
OSE Immunotherapeutics has traded in the range of 3.115 € to 11.58 € during the past year
What is the PE ratio of OSE Immunotherapeutics?
The price to earnings ratio of OSE Immunotherapeutics is -6.03
What is the cash to sales ratio of OSE Immunotherapeutics?
The cash to sales ratio of OSE Immunotherapeutics is 62.27
What is the reporting currency for OSE Immunotherapeutics?
OSE Immunotherapeutics reports financial results in EUR
What is the latest annual turnover for OSE Immunotherapeutics?
The latest annual turnover of OSE Immunotherapeutics is EUR 2.23M
What is the latest annual profit for OSE Immunotherapeutics?
The latest annual profit of OSE Immunotherapeutics is EUR -23M
What is the registered address of OSE Immunotherapeutics?
The registered address for OSE Immunotherapeutics is 22 BOULEVARD DE BENONI GOULLIN, NANTES, LOIRE-ATLANTIQUE, 44200
What is the OSE Immunotherapeutics website address?
The website address for OSE Immunotherapeutics is www.ose-immuno.com
Which industry sector does OSE Immunotherapeutics operate in?
OSE Immunotherapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLCOTCoretech 5
0.021 €
(61.54%)
102.18k
AELISAelis Farma SA
3.36 €
(46.09%)
24.42k
ALIMOGroupimo
0.182 €
(43.31%)
484
ALCWECharwood Energy SA
3.14 €
(36.52%)
10.6k
FPGUnion Tech Info
0.268 €
(26.42%)
11.65k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
818
ALTROTronic s Microsystems
3.90 €
(-28.44%)
23
ALNMRNamR SA
0.344 €
(-28.33%)
90.71k
GNROGeNeuro SA
0.1625 €
(-27.46%)
1.06M
ALOKWGroupe Okwind SA
3.30 €
(-20.29%)
35.38k
ATOAtos SE
0.0021 €
(0.00%)
1.18B
BCPBanco Comercial Portugues SA
0.5154 €
(-0.62%)
61.83M
ALCYBCybergun
0.0001 €
(0.00%)
56.47M
ALVERVergnet
0.0014 €
(0.00%)
19.39M
EDPEDP SA
2.901 €
(-0.65%)
13.72M

Discussion

View Full Feed
MasterBlastr MasterBlastr 42 seconds ago
At least they have plenty of closets over there to stash him while he sobers up.
AlwaysOptimistic AlwaysOptimistic 1 minute ago
Suggest to them that the mine be named "Trump National Critical Minerals Mine" in honor of moving the stalled project forward.

Yet another legacy project on top of his many other notable land developments. He can even open another golf course on site if he wants for free (compliments
NB
Investor2014 Investor2014 2 minutes ago
Do you mean as in “extraordinary claims,…”
I suspect that carries a significant burden of evidence.
“…require extraordinary evidence”?
AVXL
in99flyers in99flyers 8 minutes ago
1,492,795 Shiba holders. Up 1200 holders in 2 days since last post. On a collision course with 1.5 million holders. Not too bad for a meme coin with no utility 🤣
SHIBUSD
LTR LTR 8 minutes ago
My comment will get removed while yours will remain, but since you brought up AOC, you should listen to more of what she has to say. She's liberal but she's also smart and she also has integrity. I'm not surprised that she said this.
NWBO
Bass9588 Bass9588 8 minutes ago
I'd say anyone bringing politic talk to this board sounds like a moron to me
NXPL
demonsmith demonsmith 9 minutes ago
I hope for not big gap only so can load more under 0.0035 were i have 35 mil shares bid in know
TWOH
LovePennyStock LovePennyStock 11 minutes ago
https://ukaviation.news/lilium-jet-is-rescued-and-company-rebranded/amp/
Check it out this news today.
It mentioned that a Saudi group ordered 50 Lilium jets. I also remember that in an interview with Lilium CEO last year he said that the company had at least 100 firm orders for Liliu
LILMF
The Great Pumpkin The Great Pumpkin 11 minutes ago
Lightwave Logic: A Three-Decade Journey Without Commercial Success

Lightwave Logic, Inc. (NASDAQ: LWLG) has been a polarizing name in the investment community. With over 30 years in operation, the company claims to be at the forefront of photonic technology. However, its track record
LWLG
SSKILLZ1 SSKILLZ1 12 minutes ago
PSIX Was the best performing stock pick today picked by KNOWLEDGEISKING and the Best Top Pick was GRRR picked by LITTLEJOHN. hope this helps.
GRRR
TheHound TheHound 16 minutes ago
Bullish formations everywhere!
XRPUSD
WALL STREET KID WALL STREET KID 17 minutes ago
$AMC BUYS STOLEN! DARK POOL RECORD! Short Squeeze Update

https://www.youtube.com/watch?v=lEhB9EZYN90
AMC
MONTANAJOE MONTANAJOE 21 minutes ago
No,, you should hit the ignore! It makes this board so much more enjoyable and you can concentrate on what matters not claims of scam, imaginary rhodium levels, kick the can, jarhead ect!!


One press release away!!
NBRI
boston745 boston745 25 minutes ago
Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutin
SINT
Hoghead7 Hoghead7 25 minutes ago
So, I've been thinking, as always, and my original thought was these morons shorting are really committed, especially with Plug, Bloom and Ballard doing well. Volume was well below average, but, they could have done some ATM, as they have in the past nearing quarter end to solidify cash for the ear
FCEL
RKMKE RKMKE 28 minutes ago
Just to be clear, can't you read what Ken wrote? If you missed here is copied from from WinstonCup post if you have blocked him:

Decentral Life consults and licenses decentralized applications to public and private companies. TBI companies are one small part of the business model... a
WDLF
excel excel 28 minutes ago
He still has some football left in him.
Just needs a decent Oline.
He can't run for his life anymore like he did with the Seahawks. LOL!
janice shell janice shell 28 minutes ago
Me either, I'm afraid.
DTGoody DTGoody 31 minutes ago
As long as it keeps going in the right direction, I will remain optimistic. Then again 2 years is a long time to wait, and much can happen between now and then. Hoping this A.I. part of the company along with the NASDAQ spinoff works out for us?
WPFH
Susie924 Susie924 32 minutes ago
Mehdi Hasan
@mehdirhasan
·
23m
The guy who just a few years ago, by his own admission, was identified "as an extremist" by his own unit over one of his tattoos and was barred from working at President Biden's inauguration is now…Defense Secretary of the United Stated and
StockItOut StockItOut 32 minutes ago
chirp... chirp.... still no Quester explanation to his new (make-it-up-as-he-goes) claim that Xeriant's articles of association or incorporation specifically includes restriction on share transfers, thus why Xeriant did not receive XTI shares that converted to XTIA shares.


He
XTIA
Susie924 Susie924 32 minutes ago
I am not going to make it through 4 more years of him.

Your Recent History

EU
OSE
OSE Immunotherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads